Literature DB >> 8940373

Temporal and cell-type specific expression of c-fos and c-jun protooncogenes in the mouse uterus after estrogen stimulation.

S Yamashita1, A Takayanagi, N Shimizu.   

Abstract

Employing immunohistochemistry and in situ hybridization, we studied the temporal and cell type specific localization of c-Fos and c-Jun proteins and the corresponding messenger RNAs (mRNAs) elicited by a single 17beta-estradiol (E2) injection in the uteri of castrated adult mice. Cellular expression of mRNAs was in parallel with the synthesis of proteins within 1 h. E2 stimulated the c-fos expression rapidly and transiently in the epithelium and vascular endothelium. A second small peak of c-Fos protein and c-fos mRNA expression occurred around 11-13 h in the epithelium. No detectable amount of c-fos transcript and protein was present throughout the time course (0-24 h) in the stromal and myometrial cells. E2 treatment caused differential c-jun expression in all uterine cell types. In the epithelium, c-jun mRNA and protein expression was decreased during 1-6 h post injection, and thereafter returned showing small peak around 11-13 h. Induction of c-Jun protein and c-jun mRNA was evident in the stromal and myometrial cells at 2-3 h, and then the expression gradually decreased and returned to nearly control level by 24 h. E2 treatment induced rapid and transient activation of c-jun in the vascular endothelium. Present results suggest that transient increase of c-Fos and decrease of c-Jun protein at the early phase and coexpression of these proteins at the late phase contribute the proliferation of endometrial epithelium in mature mice. Furthermore, c-Fos and c-Jun expression in the vascular endothelium at the early phase may participate in the uterine imbibition.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940373     DOI: 10.1210/endo.137.12.8940373

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Role of metformin in inhibiting estrogen-induced proliferation and regulating ERα and ERβ expression in human endometrial cancer cells.

Authors:  Jingbo Zhang; Hui Xu; Xueyan Zhou; Yanyu Li; Tong Liu; Xiaoxing Yin; Bei Zhang
Journal:  Oncol Lett       Date:  2017-09-04       Impact factor: 2.967

2.  Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium.

Authors:  Sema Bircan; Arzu Ensari; Sibel Ozturk; Nural Erdogan; Ilkkan Dundar; Firat Ortac
Journal:  Pathol Oncol Res       Date:  2005-03-31       Impact factor: 3.201

3.  Lack of CCAAT enhancer binding protein beta (C/EBPbeta) in uterine epithelial cells impairs estrogen-induced DNA replication, induces DNA damage response pathways, and promotes apoptosis.

Authors:  Cyril Ramathal; Indrani C Bagchi; Milan K Bagchi
Journal:  Mol Cell Biol       Date:  2010-01-19       Impact factor: 4.272

4.  Species Comparison of the Role of p38 MAP Kinase in the Female Reproductive System.

Authors:  Zaher A Radi; Rosemary A Marusak; Dale L Morris
Journal:  J Toxicol Pathol       Date:  2009-07-07       Impact factor: 1.628

5.  Comparative temporal and dose-dependent morphological and transcriptional uterine effects elicited by tamoxifen and ethynylestradiol in immature, ovariectomized mice.

Authors:  Cora J Fong; Lyle D Burgoon; Kurt J Williams; Agnes L Forgacs; Timothy R Zacharewski
Journal:  BMC Genomics       Date:  2007-06-07       Impact factor: 3.969

6.  Curcumin Inhibits ERK/c-Jun Expressions and Phosphorylation against Endometrial Carcinoma.

Authors:  Zhenxue Zhang; Pengfei Yi; Changchun Tu; Jiejie Zhan; Liping Jiang; Fanglin Zhang
Journal:  Biomed Res Int       Date:  2019-10-31       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.